Peri-Transplant Steroids Enhance GVL and Attenuate GVHD By Redistributing Alloreactive Donor T Cells from the Gut into the Bone Marrow

被引：0

作者：

Inouye, Takayuki ^{[1
,2
]}

Koyama, Motoko ^{[1
]}

Kathleen, Ensbey ^{[1
]}

Greene, Nicholas ^{[1
]}

Samson, Luke ^{[1
]}

Ogawa, Hiroyasu ^{[2
]}

Hill, Geoffrey R. ^{[1
,3
]}

机构：

[1] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA

[2] Hyogo Coll Med, Div Hematol, Dept Internal Med, Nishinomiya, Hyogo, Japan

[3] Univ Washington, Div Med Oncol, Seattle, WA 98195 USA

来源：

BLOOD | 2019年 / 134卷

关键词：

D O I：

10.1182/blood-2019-129341

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

3210

引用

页数：3

共 50 条

[31] A novel, selective, proliferation based procedure to eliminate alloreactive T-cells induces mixed chimerism and reduces GvHD in sublethally irradiated mice receiving allogeneic bone marrow transplantation.
Pachnio, A
Dietrich, S
Klapper, W
Schulte, C
Kneba, M
Beck, C
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 178S - 178S
[32] Host Tissue PD-L1 Separates GVL Effect from Gvhd after Temporary Depletion of Donor CD4+ T Cells Early after HCT
Ni, Xiong
Song, Qingxiao
Deng, Ruishu
Jin, Hua
Cassady, Kaniel M.
Zhang, Mingfeng
Forman, Stephen J.
Martin, Paul J.
Wang, Jianmin
Zeng, Defu
BLOOD, 2015, 126 (23)
[33] In Vitro expanded STAT1-/- Regulatory T Cells Prevent Acute Graft Versus Host Disease (GVHD) and Promote Donor Cell Engraftment In Allogeneic Fully MHC-Mismatched Bone Marrow Transplant
Ma, Huihui
Lu, Caisheng
Ziegler, Judy
Lentzsch, Suzanne
Mapara, Markus Y.
BLOOD, 2010, 116 (21) : 323 - 323
[34] Characterization of Cytotoxic T Lymphocyte Clones Isolated from Bone Marrow Transplant Recipient with HLA-Cw-Mismatched Donor.
Sugimoto, Kyoko
Murata, Makoto
Terakura, Seitaro
Naoe, Tomoki
BLOOD, 2008, 112 (11) : 453 - 453
[35] Donor T cells lacking Fas ligand, and perforin retain the capacity to induce severe GvHD in minor histocompatibility antigen mismatched bone-marrow transplantation recipients
Marks, L
Altman, NH
Podack, ER
Levy, RB
TRANSPLANTATION, 2004, 77 (06) : 804 - 812
[36] Addition of cyclophosphanmide to T-cell depletion-based nonmyeloablative conditioning allows donor T-cell engraftment and clonal deletion of alloreactive host T-cells after bone marrow transplantation
Xu, Hong
Chilton, Paula M.
Huang, Yiming
Schanie, Carrie L.
Yan, Jun
Ildstad, Suzanne T.
TRANSPLANTATION, 2007, 83 (07) : 954 - 963
[37] Graft versus host disease (GVHD) in a rat small bowel transplant model after T-cell depleted donor specific bone marrow (TCD-DSBM) infusion.
Bakonyi, A
DeFaria, W
Vennarecci, G
Misiakos, E
Carreno, M
Quintero, J
Sommariva, A
Feo, C
Berho, M
Esquenazi, V
Ruiz, P
Miller, J
Ricordi, C
Tzakis, AG
TRANSPLANTATION, 1999, 67 (09) : S648 - S648
[38] Stat3-/- Alloreactive Donor T Cells Reduce FAO but Increase Leakage of ROS in Response to PD-1 Signaling Triggered By Host-Tissue PD-L1, Leading to Prevention of Gvhd While Preserving GVL Effect
Wang, Xiaoqi
Yang, Shijie
Wang, Yating
Wu, Xiwei
Salas, Martha
Song, Qingxiao
Qin, Hanjun
Nasri, Ubaydah
Riggs, Arthur D.
Martin, Paul J.
Zhang, Xi
Zeng, Defu
BLOOD, 2019, 134
[39] Selective Depletion of Alloreactive Donor T Cells with Adenosine: An Efficient, Scaleable, GMP-Compliant, Low-Cost Method to Prevent Gvhd While Preserving Antiviral and Antileukemic Activity in Haploidentical Stem Cell Transplant
Whitehill, Greg
Amarnath, Shoba
Keyvanfar, Keyvan
Muranski, Pawel
Battiwalla, Minoo
Barrett, Austin John
Chinnasamy, Dhana
BLOOD, 2015, 126 (23)
[40] A PHASE 1 PERSPECTIVE: MULTIVIRUS-SPECIFIC T CELLS FROM BOTH CORD BLOOD AND BONE MARROW TRANSPLANT DONORS
Hanley, Patrick J.
Keller, Michael D.
Manso, Maria Gema Martin
Martinez, Caridad
Leung, Kathryn S.
Cruz, Conrad R.
Barese, Cecilia
McCormack, Sarah
Luo, Min
Krance, Bob R.
Jacobsohn, David
Rooney, Cliona M.
Heslop, Helen E.
Shpall, E. J.
Bollard, Catherine M.
PEDIATRIC BLOOD & CANCER, 2016, 63 : S101 - S102

← 1 2 3 4 5 →